CXCL10 and obesity disorder: Increased circulatory levels of IP-10 have been also documented in metabolic inflammatory conditions, such as obesity and type-2 diabetes mellitus (T2DM), and elevated IP-10 levels in patients with T2DM were related with insulin resistance [11].